These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 737877)

  • 1. Junctional naevi following toxic epidermal necrolysis.
    Burns DA; Sarkany I
    Clin Exp Dermatol; 1978 Sep; 3(3):323-6. PubMed ID: 737877
    [No Abstract]   [Full Text] [Related]  

  • 2. Eruptive melanocytic naevi following severe bullous disease.
    Kirby JD; Darley CR
    Br J Dermatol; 1978 Nov; 99(5):575-80. PubMed ID: 708632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eruptive nevocytic nevi after severe bullous disease.
    Kopf AW; Grupper C; Baer RL; Mitchell JC
    Arch Dermatol; 1977 Aug; 113(8):1080-4. PubMed ID: 329772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Nevi in a Patient After Toxic Epidermal Necrolysis.
    Balić A; Pavičić B; Marinović B; Jurakić Tončić R
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):183-185. PubMed ID: 29989878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eruptive melanocytic nevi after Stevens-Johnson syndrome.
    Shoji T; Cockerell CJ; Koff AB; Bhawan J
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):337-9. PubMed ID: 9270542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient verrucous hyperplasia after toxic epidermal necrolysis.
    García-Doval I; Flórez A; De La Torre C; Conde A; Cruces MJ
    Br J Dermatol; 2003 Nov; 149(5):1082-3. PubMed ID: 14632826
    [No Abstract]   [Full Text] [Related]  

  • 7. [Eruptive nevus in the course of Lyell syndrome].
    Jullien D; Prévot G; Wolkenstein P; Roujeau JC; Revuz J
    Ann Dermatol Venereol; 1995; 122(8):540-2. PubMed ID: 8572497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eruptive melanocytic nevi during azathioprine therapy for antisynthetase syndrome.
    Steinweg SA; Halvorson CR; Kao GF; Dronavalli S
    Cutis; 2017 Apr; 99(4):268-270. PubMed ID: 28492593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess benign melanocytic naevi.
    Hughes B; Bailey CC
    BMJ; 1989 Sep; 299(6703):854-5. PubMed ID: 2510859
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA; Goldstein DM
    Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early gynaecological assessment following Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Madhuri TK; Kremer C
    J Obstet Gynaecol; 2010; 30(8):871-2. PubMed ID: 21126137
    [No Abstract]   [Full Text] [Related]  

  • 17. Eruptive nevocytic nevi after Lyell's syndrome.
    Goerz G; Tsambaos D
    Arch Dermatol; 1978 Sep; 114(9):1400-1. PubMed ID: 686763
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.